UPSHER SMITH LABS FDA Approval ANDA 062524

ANDA 062524

UPSHER SMITH LABS

FDA Drug Application

Application #062524

Application Sponsors

ANDA 062524UPSHER SMITH LABS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL500,000 UNITS0NYSTATINNYSTATIN

FDA Submissions

ORIG1AP1985-11-26
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1993-07-16
LABELING; LabelingSUPPL8AP1992-09-11

Submissions Property Types

SUPPL7Null0

CDER Filings

UPSHER SMITH LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62524
            [companyName] => UPSHER SMITH LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"NYSTATIN","activeIngredients":"NYSTATIN","strength":"500,000 UNITS","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NYSTATIN","submission":"NYSTATIN","actionType":"500,000 UNITS","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.